Tim-3在药物性急性肾损伤动物模型中的表达及作用机制

doi:10.6040/j.issn.1671-7554.0.2020.0392

摘要/Abstract

摘要： 目的探索T细胞免疫球蛋白黏蛋白分子3(Tim-3)在急性肾损伤(AKI)中的作用,并研究其作用机制。方法将6~8周C57雄性小鼠随机分为对照组(CTRL组)、顺铂组(AKI组)及顺铂+阻断Tim-3组(RMT组),每组4只,AKI组使用顺铂(20 mg/kg)腹腔注射,构建AKI动物模型,检测肾脏损伤情况与Tim-3表达情况。RMT组使用抗体RMT3-23(200 μg/只)阻断Tim-3分子,建立AKI模型,检测AKI组与RMT组肾脏损伤情况以及Tim-3、自噬相关分子的表达情况。结果肾脏近端小管出现损伤,Western blotting 结果显示 AKI组Tim-3表达水平较CTRL组增加(t=3.876,P=0.008 2)。与AKI组相比,RMT组的NGAL和P62表达水平均增高,但差异无统计学意义(t_NGAL=1.664,P=0.157 0;t_P62=1.991,P=0.103 1),LC3II表达下降,差异有统计学意义(t=5.901,P=0.002 0),自噬受到抑制且肾脏小管损伤加重(P=0.010 1)。结论 Tim-3可以通过调节肾小管上皮细胞自噬活性,减轻顺铂诱导的AKI肾损伤。

关键词: T细胞免疫球蛋白黏蛋白分子3, 急性肾损伤, 顺铂, 自噬, 小鼠

Abstract: Objective To explore the role of T cell immunoglobulin domain and mucin domain protein-3(Tim-3)in acute kidney injury(AKI)and study its mechanism. Methods Six to eight weeks old C57 male mice were randomly divided into the control group(CTRL group), cisplatin group(AKI group), and cisplatin + Tim-3 group(RMT group), 4 in each group. Cisplatin(20 mg/kg)was injected intraperitoneally into the mice in the AKI group to construct the AKI animal model, and kidney injury and Tim-3 expression were detected. In RMT group, the antibody RMT3-23(200 μg/per mouse)was used to block the Tim-3 molecule and to establish an AKI model, and then the kidney injury in the AKI and RMT groups and the expressions of Tim-3 and autophagy-related molecules were detected. Results The renal proximal tubules were damaged. Western blotting results showed that the expression level of Tim-3 in AKI group was higher than that in CTRL group (t=3.876, P=0.008 2). Compared with the AKI group, the expression levels of NGAL and P62 in the RMT group increased without the statistical difference(t_NGAL=1.664, P=0.157 0; t_P62=1.991, P=0.103 1), while the expression of LC3II decreased with a statistical difference(t=5.901, P=0.002 0). The phagocytosis was inhibited and the renal tubular damage was aggravated(P=0.010 1). Conclusion Tim-3 can reduce AKI renal injury induced by cisplatin by regulating the autophagic activity of renal tubular epithelial cells.

Key words: T cell immunoglobulin domain and mucin domain protein-3, Acute kidney injury, Cisplatin, Autophagy, Mouse

中图分类号:

R574

索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1-6.

SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1-6.

参考文献 34

[1]	涂玉凤,赵馥. 噬血细胞综合征伴急性肾损伤1例[J].山东大学学报(医学版), 2019, 57(6): 117-121.
[2]	葛均克,赵升田. 骨髓间充质干细胞与CD133+肾脏细胞对急性肾损伤的疗效[J].山东大学学报(医学版),2013,51(9): 55-59. GE Junke, ZHAO Shengtian. Protective effect of bone marrow mesenchymal stem cells and CD133+ renal cells on acute renal injury [J]. Journal of Shandong University(Health Sciences), 2013, 51(9): 55-59.
[3]	Periyasamy-Thandavan S, Jiang M, Schoenlein P, et al. Autophagy: molecular machinery, regulation, and implications for renal pathophysiology [J]. Am J Physiol Renal Physiol, 2009, 297(2): F244-F256.
[4]	Jiang M, Wei Q, Dong G, et al. Autophagy in proximal tubules protects against acute kidney injury [J]. Kidney Int, 2012, 82(12): 1271-1283.
[5]	Periyasamy-Thandavan S, Jiang M, Wei Q, et al. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells [J]. Kidney Int, 2008, 74(5): 631-640.
[6]	Kaushal GP, Kaushal V, Herzog C, et al. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity [J]. Autophagy, 2008, 4(5): 710-712.
[7]	Takahashi A, Kimura T, Takabatake Y, et al. Autophagy guards against cisplatin-induced acute kidney injury[J]. Am J Pathol, 2012, 180(2): 517-525.
[8]	Han G, Chen G, Shen B, et al. Tim-3: an activation marker and activation limiter of innate immune cells[J]. Front Immunol, 2013, 4: 449-449. doi: 10.3389/fimmu.2013.00449.
[9]	Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses[J]. Curr Top Microbiol Immunol, 2011, 350: 1-15. doi: 10.1007/82_2010_84.
[10]	Tang R, Rangachari M, Kuchroo VK. Tim-3: a co-receptor with diverse roles in T cell exhaustion and tolerance[J]. Semin Immunol, 2019, 42: 101302. doi: 10.1016/j.smim.2019.101302.
[11]	Sakuishi K, Jayaraman P, Behar SM, et al. Emerging Tim-3 functions in antimicrobial and tumor immunity[J]. Trends Immunol, 2011, 32(8): 345-349.
[12]	陶景莲, 李丽娟, 邵宗鸿. TIM3在肿瘤微环境中作用的研究进展[J]. 中国免疫学杂志, 2016, 32(7): 1070-1073.
[13]	马艳苗, 王永辉, 周然. 肾脏病理损伤评价在实验和临床研究中的应用前景[J]. 世界中西医结合杂志, 2010, 5(3): 266-268.
[14]	Bellomo R, Kellum JA, Ronco C. Acute kidney injury[J]. Lancet, 2012, 380(9843): 756-766.
[15]	Martin RK. Acute kidney injury: advances in definition, pathophysiology, and diagnosis[J]. AACN Adv Crit Care, 2010, 21(4): 350-356.
[16]	Mehta RL, Awdishu L, Davenport A, et al. Phenotype standardization for drug-induced kidney disease[J]. Kidney Int, 2015, 88(2): 226-234.
[17]	Lameire NH, Bagga A, Cruz D, et al. Acute kidney injury: an increasing global concern[J]. Lancet, 2013, 382(9887): 170-179.
[18]	林丹欣, 杜斌. 急性肾损伤的液体管理[J]. 心肺血管病杂志 2019, 38(11): 1188-1191.
[19]	Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance[J]. Nat Immunol, 2003, 4(11): 1093-1101.
[20]	Schroll A, Eller K, Huber JM, et al. Tim3 is upregulated and protective in nephrotoxic serum nephritis[J]. Am J Pathol, 2010, 176(4): 1716-1724.
[21]	Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway[J]. Mol Metab, 2019, 23: 24-36. doi: 10.1016/j.molmet.2019.02.007.
[22]	Guo Y, Zhang J, Lai X, et al. Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation[J]. Clin Exp Immunol, 2018, 193(1): 113-129.
[23]	Izzedine H, Perazella MA. Anticancer drug-induced acute kidney injury[J]. Kidney Int Rep, 2017, 2(4): 504-514.
[24]	Filipski KK, Mathijssen RH, Mikkelsen TS, et al. Contribution of organic cation transporter 2(OCT2)to cisplatin-induced nephrotoxicity[J]. Clin Pharmacol Ther, 2009, 86(4): 396-402.
[25]	Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury[J]. Biomed Res Int, 2014, 2014: 967826. doi: 10.1155/2014/967826.
[26]	Wisnovsky SP, Wilson JJ, Radford RJ, et al. Targeting mitochondrial DNA with a platinum-based anticancer agent[J]. Chem Biol, 2013, 20(11): 1323-1328.
[27]	Dall KB, Færgeman NJ. Metabolic regulation of lifespan from a C. elegans perspective[J]. Genes Nutr, 2019, 14: 25. doi: 10.1186/s12263-019-0650-x.
[28]	Xu Y, Ma H, Shao J, et al. A role for tubular necroptosis in cisplatin-induced AKI[J]. J Am Soc Nephrol, 2015, 26(11): 2647-2658.
[29]	Lee YK, Lee JA. Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy[J]. BMB Rep, 2016, 49(8): 424-430.
[30]	Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor[J]. FEBS J, 2015, 282(24): 4672-4678.
[31]	Sánchez-Martín P, Komatsu M. p62/SQSTM1-steering the cell through health and disease[J]. J Cell Sci, 2018, 131(21): jcs222836. doi: 10.1242/jcs.222836.
[32]	Ichimura Y, Kominami E, Tanaka K, et al. Selective turnover of p62/A170/SQSTM1 by autophagy[J]. Autophagy, 2008, 4(8): 1063-1066.
[33]	Komatsu M. Potential role of p62 in tumor development[J]. Autophagy, 2011, 7(9): 1088-1090.
[34]	Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy[J]. Semin Immunopathol, 2010, 32(4): 431-436.

相关文章 15

[1]	杨晓倩季静刘娜郭冬梅崔癉. 三氯化铁及络合铁的抗银屑病作用研究[J]. 山东大学学报(医学版), 2209, 47(6): 114-117.
[2]	段淑红刘凯尹海燕赵世斗刘丰韬. 凝集素受体WGA、RCA和ECL在过量维甲酸致昆明小鼠腭裂发生中的作用[J]. 山东大学学报(医学版), 2209, 47(6): 47-.
[3]	董萍,沈海涛,乔亚琴,路燕. 自噬在APAP肝损伤及肝再生过程中的调控作用[J]. 山东大学学报 (医学版), 2026, 64(5): 42-49.
[4]	陈杨,冯莹,卢晓,郑蓉. 半乳糖凝集素-3通过PI3K/Akt/mTOR通路促进巨噬细胞自噬分化[J]. 山东大学学报 (医学版), 2026, 64(4): 14-22.
[5]	张秋萍,朱慧志,吕川,夏咏琪,张秀. 基于生物信息学分析鉴定哮喘潜在的关键自噬和铁死亡相关基因[J]. 山东大学学报 (医学版), 2026, 64(1): 74-87.
[6]	宋彦威,付振美,徐静怡,马铭泽,孙琳琳. 弗林蛋白酶靶向同源性磷酸-张力蛋白调控线粒体自噬及肝纤维化进展[J]. 山东大学学报 (医学版), 2025, 63(4): 59-68.
[7]	蔡佳莹,王靖婷,王增萍,王璟,郏雁飞,马晓丽. α5-nAChR对慢性应激肺腺癌荷瘤小鼠疑核c-Fos表达的影响[J]. 山东大学学报 (医学版), 2025, 63(4): 69-74.
[8]	武琪琪,成淼淼,肖晓燕. 多模态模型在肾脏病领域的应用[J]. 山东大学学报 (医学版), 2025, 63(10): 117-124.
[9]	刘爱静,李雁儒,高惠茹,段伟丽,李培龙,李娟,杜鲁涛,王传新. 自噬相关蛋白5在结肠癌中的表达及对结肠癌细胞迁移及侵袭能力的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 14-23.
[10]	古玥琳,肖晓. 小鼠二选一赌博实验范式设计及验证[J]. 山东大学学报 (医学版), 2024, 62(3): 1-10.
[11]	于丽,王弋嘉,杨勇,刘学焕,万雪花,包翠萍,苗蓓亮,李斯琪,李静,刘筠. 基于光学表面波技术探究具核梭杆菌介导的自噬与细胞折射率的关系[J]. 山东大学学报 (医学版), 2024, 62(10): 87-97.
[12]	王亚楠,梁传杰,贾梦琪,苑辉卿. 二硫键异构酶TMX1促进肺癌化疗耐药[J]. 山东大学学报 (医学版), 2023, 61(8): 31-39.
[13]	郑荣慧,李攀,曹秀琴,贺瑞霞,陈民佳,陈海霞,杨志伟. SQSTM1蛋白在嗜肺军团菌感染RAW264.7细胞自噬中的作用机制[J]. 山东大学学报 (医学版), 2023, 61(6): 10-21.
[14]	任慧欣,郑茂金,韩文灿,王超群,周云,裴冬生. 过氧化氢通过调控自噬增强宫颈癌的放疗敏感性[J]. 山东大学学报 (医学版), 2023, 61(6): 22-28.
[15]	何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed